These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
385 related articles for article (PubMed ID: 25706559)
1. S100A9 induced inflammatory responses are mediated by distinct damage associated molecular patterns (DAMP) receptors in vitro and in vivo. Chen B; Miller AL; Rebelatto M; Brewah Y; Rowe DC; Clarke L; Czapiga M; Rosenthal K; Imamichi T; Chen Y; Chang CS; Chowdhury PS; Naiman B; Wang Y; Yang D; Humbles AA; Herbst R; Sims GP PLoS One; 2015; 10(2):e0115828. PubMed ID: 25706559 [TBL] [Abstract][Full Text] [Related]
2. TLR4 and RAGE conversely mediate pro-inflammatory S100A8/9-mediated inhibition of proliferation-linked signaling in myeloproliferative neoplasms. Kovačić M; Mitrović-Ajtić O; Beleslin-Čokić B; Djikić D; Subotički T; Diklić M; Leković D; Gotić M; Mossuz P; Čokić VP Cell Oncol (Dordr); 2018 Oct; 41(5):541-553. PubMed ID: 29946821 [TBL] [Abstract][Full Text] [Related]
3. Proinflammatory effects of S100A8/A9 via TLR4 and RAGE signaling pathways in BV-2 microglial cells. Ma L; Sun P; Zhang JC; Zhang Q; Yao SL Int J Mol Med; 2017 Jul; 40(1):31-38. PubMed ID: 28498464 [TBL] [Abstract][Full Text] [Related]
4. Computational Deciphering of the Role of S100A8 and S100A9 Proteins and Their Changes in the Structure Assembly Influences Their Interaction with TLR4, RAGE, and CD36. Paramasivam S; Perumal SS; Ekambaram SP Protein J; 2024 Apr; 43(2):243-258. PubMed ID: 38431537 [TBL] [Abstract][Full Text] [Related]
5. Colon-targeted S100A8/A9-specific peptide systems ameliorate colitis and colitis-associated colorectal cancer in mouse models. Cho E; Mun SJ; Kim HK; Ham YS; Gil WJ; Yang CS Acta Pharmacol Sin; 2024 Mar; 45(3):581-593. PubMed ID: 38040838 [TBL] [Abstract][Full Text] [Related]
6. Deficiency of S100 calcium binding protein A9 attenuates vascular dysfunction in aged mice. Zhao B; Yu J; Luo Y; Xie M; Qu C; Shi Q; Wang X; Zhao X; Kong L; Zhao Y; Guo Y Redox Biol; 2023 Jul; 63():102721. PubMed ID: 37163872 [TBL] [Abstract][Full Text] [Related]
7. Functional characterization of S100A8 and S100A9 in altering monolayer permeability of human umbilical endothelial cells. Wang L; Luo H; Chen X; Jiang Y; Huang Q PLoS One; 2014; 9(3):e90472. PubMed ID: 24595267 [TBL] [Abstract][Full Text] [Related]
8. The roles of toll-like receptor 4, CD33, CD68, CD69, or CD147/EMMPRIN for monocyte activation by the DAMP S100A8/S100A9. Möller A; Jauch-Speer SL; Gandhi S; Vogl T; Roth J; Fehler O Front Immunol; 2023; 14():1110185. PubMed ID: 37056775 [TBL] [Abstract][Full Text] [Related]
9. S100A9 Increases IL-6 and RANKL Expressions through MAPKs and STAT3 Signaling Pathways in Osteocyte-Like Cells. Takagi R; Sakamoto E; Kido JI; Inagaki Y; Hiroshima Y; Naruishi K; Yumoto H Biomed Res Int; 2020; 2020():7149408. PubMed ID: 32149126 [TBL] [Abstract][Full Text] [Related]
10. Serum levels of soluble receptor for advanced glycation end products and of S100 proteins are associated with inflammatory, autoantibody, and classical risk markers of joint and vascular damage in rheumatoid arthritis. Chen YS; Yan W; Geczy CL; Brown MA; Thomas R Arthritis Res Ther; 2009; 11(2):R39. PubMed ID: 19284577 [TBL] [Abstract][Full Text] [Related]
11. S100A8, S100A9 and S100A12 activate airway epithelial cells to produce MUC5AC via extracellular signal-regulated kinase and nuclear factor-κB pathways. Kang JH; Hwang SM; Chung IY Immunology; 2015 Jan; 144(1):79-90. PubMed ID: 24975020 [TBL] [Abstract][Full Text] [Related]
12. S100A9 and HMGB1 orchestrate MDSC-mediated immunosuppression in melanoma through TLR4 signaling. Özbay Kurt FG; Cicortas BA; Balzasch BM; De la Torre C; Ast V; Tavukcuoglu E; Ak C; Wohlfeil SA; Cerwenka A; Utikal J; Umansky V J Immunother Cancer; 2024 Sep; 12(9):. PubMed ID: 39266214 [TBL] [Abstract][Full Text] [Related]
13. RAGE-dependent regulation of calcium-binding proteins S100A8 and S100A9 in human THP-1. Eggers K; Sikora K; Lorenz M; Taubert T; Moobed M; Baumann G; Stangl K; Stangl V Exp Clin Endocrinol Diabetes; 2011 Jun; 119(6):353-7. PubMed ID: 21472666 [TBL] [Abstract][Full Text] [Related]
14. S100A9 promotes human lung fibroblast cells activation through receptor for advanced glycation end-product-mediated extracellular-regulated kinase 1/2, mitogen-activated protein-kinase and nuclear factor-κB-dependent pathways. Xu X; Chen H; Zhu X; Ma Y; Liu Q; Xue Y; Chu H; Wu W; Wang J; Zou H Clin Exp Immunol; 2013 Sep; 173(3):523-35. PubMed ID: 23682982 [TBL] [Abstract][Full Text] [Related]
15. The metastasis-associated protein S100A4 promotes the inflammatory response of mononuclear cells via the TLR4 signalling pathway in rheumatoid arthritis. Cerezo LA; Remáková M; Tomčik M; Gay S; Neidhart M; Lukanidin E; Pavelka K; Grigorian M; Vencovský J; Šenolt L Rheumatology (Oxford); 2014 Aug; 53(8):1520-6. PubMed ID: 24643522 [TBL] [Abstract][Full Text] [Related]
16. Advanced glycation end products increase expression of S100A8 and A9 via RAGE-MAPK in rat dental pulp cells. Nakajima Y; Inagaki Y; Kido J; Nagata T Oral Dis; 2015 Apr; 21(3):328-34. PubMed ID: 25098709 [TBL] [Abstract][Full Text] [Related]
17. S100A9-induced release of interleukin (IL)-6 and IL-8 through toll-like receptor 4 (TLR4) in human periodontal ligament cells. Gao H; Zhang X; Zheng Y; Peng L; Hou J; Meng H Mol Immunol; 2015 Oct; 67(2 Pt B):223-32. PubMed ID: 26038301 [TBL] [Abstract][Full Text] [Related]
18. High expression of S100 calgranulin genes in peripheral blood mononuclear cells from patients with Takayasu arteritis. Kabeerdoss J; Thomas M; Goel R; Mohan H; Danda S; L J; Danda D Cytokine; 2019 Feb; 114():61-66. PubMed ID: 30594066 [TBL] [Abstract][Full Text] [Related]
19. Alarmins S100A8 and S100A9 elicit a catabolic effect in human osteoarthritic chondrocytes that is dependent on Toll-like receptor 4. Schelbergen RF; Blom AB; van den Bosch MH; Slöetjes A; Abdollahi-Roodsaz S; Schreurs BW; Mort JS; Vogl T; Roth J; van den Berg WB; van Lent PL Arthritis Rheum; 2012 May; 64(5):1477-87. PubMed ID: 22127564 [TBL] [Abstract][Full Text] [Related]
20. Identification of human S100A9 as a novel target for treatment of autoimmune disease via binding to quinoline-3-carboxamides. Björk P; Björk A; Vogl T; Stenström M; Liberg D; Olsson A; Roth J; Ivars F; Leanderson T PLoS Biol; 2009 Apr; 7(4):e97. PubMed ID: 19402754 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]